UBS Group »

Gyre Therapeutics Incorporated shares owned by UBS Group

Quarter-by-quarter ownership of Gyre Therapeutics Incorporated (GYRE) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Gyre Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Gyre Therapeutics Incorporated held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gyre Therapeutics Incorporated by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $171k 23k 7.46
2025-06-30 $64k 8.6k 7.35
2025-03-31 $188k 24k 7.72
2024-12-31 $691k 57k 12.10
2024-09-30 $46k 3.6k 12.54
2024-06-30 $25k 2.1k 11.93
2023-12-31 $8.6k 333 25.69